Trials / Terminated
TerminatedNCT00692614
A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)
A Phase IIb, Randomized, Masked, Sham-Controlled, Clinical Trial to Study the Efficacy and Safety of the Helical Triamcinolone Acetonide Implant (MK0140) in Diabetic Patients With Clinically Significant Macular Edema
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the treatment effect of three doses of the I-vation TA implant (MK0140) in diabetic patients with clinically significant macular edema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | triamcinolone acetonide | 100 mcg; 500 mcg; 925 mcg triamcinolone acetonide on helical coil implant to elute over 12 months. |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2008-06-06
- Last updated
- 2015-11-02
Source: ClinicalTrials.gov record NCT00692614. Inclusion in this directory is not an endorsement.